Solarix Plans Forest, Virginia, Solar Module Operations
08/04/2024
The new solar module manufacturing facility will be located in the former TEVA Pharmaceutical building. Production is scheduled to begin by July 2025.
“As a 100% American-owned and managed company, we are immensely proud to contribute to our nation’s energy independence,” said Carlos Class, CEO and co-founder of Solarix. “By reclaiming control of our supply chain from foreign manufacturers, we are safeguarding our electric grid infrastructure, ensuring its resilience for decades to come. This is not just a business endeavor; it is a commitment to U.S. national security and a sustainable future.”
Solarix is a solar energy firm that is dedicated to manufacturing clean energy solutions for the U.S. and international markets. The company serves the residential, commercial, and utility sectors.
“The partners and investors were familiar with Virginia,” noted Megan Lucas, CEO and chief economic development officer of Lynchburg Regional Business Alliance. “They were also looking for a building of this size, a large existing manufacturing facility, and that’s what brought their eyes to our market.”
Project Announcements
SencorpWhite Plans Hamilton, Ohio, Headquarters-Manufacturing Operations
12/29/2025
Kraken Technologies Limited Plans New York City Headquarters Operations
12/29/2025
Lupin Expands Coral Springs, Florida, Operations
12/29/2025
KPPC Advanced Chemicals Expands Casa Grande, Arizona, Operations
12/29/2025
Volvo Group Plans Tacoma, Washington, Distribution Operations
12/29/2025
Alnylam Pharmaceuticals Expands Norton, Massachusetts, Operations
12/29/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025